BECTON DICKINSON & CO is 28.2x more valuable than AtriCure, Inc. by market capitalization ($40.51 B vs $1.44 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ATRC | BDX |
|---|---|---|
| Market cap | $1.44 B | $40.51 B |
| US-listed rank | #2374 | #375 |
| Revenue (latest FY) | $534.53M | $21.84B |
| Net income (latest FY) | -$11.45M | $1.68B |
| Net margin | -2.1% | 7.7% |
| P/E (trailing FY) | - | 24.1 |
| SEC filings | 1,531 | 3,027 |
BECTON DICKINSON & CO is 28.2x more valuable than AtriCure, Inc. by market capitalization ($40.51 B vs $1.44 B).
In their latest fiscal years, AtriCure, Inc. reported $534.53M in revenue while BECTON DICKINSON & CO reported $21.84B.
Full pages: AtriCure, Inc. and BECTON DICKINSON & CO, or browse the full rankings.